Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    Pharma need to keep their ‘pull & push’ separate from their ‘inbound & outbound’

    White Papers and Resources | August 8, 2017 | An agency called Owen

    Is your pharma brand using the marketing terms ‘pull & push’ correctly?

    A man walks into a surgery: The role of storytelling in pharma marketing

    White Papers and Resources | August 4, 2017 | Life Healthcare Communications

    Communicating through stories can make your brand messages more meaningful, memorable and persuasive

    Embracing the demands of the empowered ‘consumer-savvy’ patient by Ann Generlich

    White Papers and Resources | August 3, 2017 | Say Communications

    Our access to information, which is now constantly at our fingertips and the explosion of new technologies has shifted the buying power to increasingly ‘consumer-savvy’ patients. These are patients who choose...

    The Art of Agile Marketing

    White Papers and Resources | August 3, 2017 | Anthill Agency

    The industry knows that it needs become more responsive to its stakeholders. An agile approach – which quickly improves results through a process of rapid market feedback and response –...

    Could ketamine be the next big thing in depression?

    White Papers and Resources | August 3, 2017 | Blue Latitude Health

    Account Executive Will Frostick discusses the established treatment model for depression and its limitations, as well as a new entrant poised to revolutionise the field – ketamine.

    Attracting doctors to low-demand specialties: A role for industry?

    White Papers and Resources | August 3, 2017 | Porterhouse Medical Group

     One of the major problems that healthcare systems around the world face is a paucity of medically qualified staff entering particular specialties and subspecialties. This can be due to a...

    Men vs Women in emerging markets

    White Papers and Resources | August 2, 2017 | Inizio

    Our latest interactive infographic compares male vs female health characteristics in the BRIC emerging marketS

    South Korea: The next global player?

    White Papers and Resources | August 2, 2017 | Inizio

    In this paper, we will explore some of the key trends and outlooks for South Korea in more detail, including what lies behind its presence at the extremes of two...

    20 questions: Round 4

    White Papers and Resources | August 2, 2017 | Inizio

    As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month "What’s been the funniest thing to happen to you whilst you’ve...

    Will gene therapies finally be commercially viable to pharma?

    White Papers and Resources | August 2, 2017 | Inizio

    Our latest Free Thinking white paper explores the science behind the idea of gene therapy and takes a look at some of the core challenges medical researchers have faced when...